# Rocket Pharmaceuticals, Inc.: Form 8-K, filed Jun 12, 2026

- Company: [Rocket Pharmaceuticals, Inc.](/companies/rckt.md) (CIK 1281895)
- Form: 8-K
- Filed: 2026-06-12
- Accepted by EDGAR: Jun 12, 2026, 07:10 ET
- Period: 2026-06-10
- Accession: 0001140361-26-024997
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1281895/000114036126024997/ef20076119_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1281895/000114036126024997/

## Items reported

- Item 2.01: Completion of an acquisition or disposition
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1281895/000114036126024997/ef20076119_8k.htm

Filed Jun 12, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-024997. Last ingested by Listed: Oct 30, 2026, 13:58 ET. No prices; not investment advice.